Cargando…

The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study

BACKGROUND: The major aim of this study was evaluating the effect of atorvastatin treatment on thiobarbituric acid reactive substances (TBARS), ferric reducing the ability of plasma (FRAP), small dense low-density lipoprotein cholesterol (sdLDL) and lipid profile in coronary artery disease (CAD) pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahsavari, Gholamreza, Raoufi, Amir, Toolabi, Aram, Hosseninejadmir, Nahid, Ahmadvand, Hassan, Safariebrahimsarabie, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889919/ https://www.ncbi.nlm.nih.gov/pubmed/29643923

Ejemplares similares

Amelioration of lipid peroxidation in vivo and in vitro by Satureja khozestanica essential oil in alloxan-induced diabetic rats
por: Ahmadvand, Hassan, et al.
Publicado: (2014)

Lipid peroxidation is not associated with adipocytokines in preeclamptic women
por: Khosrowbeygi, Ali, et al.
Publicado: (2011)

Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin
por: Pordal, Amir-Hamzeh, et al.
Publicado: (2015)

Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease
por: Zhao, Yuhong, et al.
Publicado: (2017)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome
por: Umrani, Salman, et al.
Publicado: (2020)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Bidram, Peyman, et al.
Publicado: (2015)

Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome
por: Vondrakova, Dagmar, et al.
Publicado: (2010)

Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
por: Xu, Danyan, et al.
Publicado: (2017)

Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension
por: Sepehri, Zahra, et al.
Publicado: (2016)

Vitamin D Levels and Lipid Response to Atorvastatin
por: Pérez-Castrillón, José Luis, et al.
Publicado: (2010)

The effects of atorvastatin therapy on endothelıal function in patients with coronary artery disease
por: Yildiz, Ahmet, et al.
Publicado: (2007)

Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells
por: Strohbach, Anne, et al.
Publicado: (2016)

Correction: Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension
por: Sepehri, Zahra, et al.
Publicado: (2017)

Effects of Atorvastatin on Nitrate Tolerance in Diabetic Rats
por: Imenshahidi, Mohsen, et al.
Publicado: (2010)

Effect of CETP Polymorphism on Atorvastatin Lipid-Regulating Effect and Clinical Prognosis of Patients with Coronary Heart Disease
por: Gu, Guo-Long, et al.
Publicado: (2014)

Biochemical effects of oleuropein in gentamicin-induced nephrotoxicity in rats
por: Ahmadvand, Hassan, et al.
Publicado: (2016)

Comprehensive Study of Atorvastatin Nanostructured Lipid Carriers through Multivariate Conceptualization and Optimization
por: Ghanem, Heba A., et al.
Publicado: (2021)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Comparing the combination therapy of ezetimibe and atorvastatin with atorvastatin monotherapy for regulating blood lipids: a systematic review and meta-analyse
por: Ai, Cong, et al.
Publicado: (2018)

ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses
por: Yang, Qian, et al.
Publicado: (2018)

Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow
por: Niu, Hongmei, et al.
Publicado: (2018)

Use of Atorvastatin in Lipid Disorders and Cardiovascular Disease in Chinese Patients
por: Ye, Yi-Cong, et al.
Publicado: (2015)

Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids
por: Zimmermann, Friederike, et al.
Publicado: (2020)

Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013)

Effect of Atorvastatin on Serial Changes in Coronary Physiology and Plaque Parameters
por: Lee, Cheol Hyun, et al.
Publicado: (2022)

Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran
por: Ahmadvand, Alireza, et al.
Publicado: (2015)

Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
por: Dalli, Jesmond, et al.
Publicado: (2015)

Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Cholesteryl Ester Transfer Protein Gene and Effectiveness of Lipid Lowering of Atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2010)

Comparative Study of Ezetimibe and Atorvastatin Alone and in Combination on Lipid Profile in Rats
por: Prasad, Anju, et al.
Publicado: (2013)

De novo coronary artery disease in graves’ disease. coincidence?
por: Shahsavari, Dariush, et al.
Publicado: (2018)

Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy
por: Zhang, Qing-Hui, et al.
Publicado: (2018)

Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2012)

Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
por: Lee, Yong-Joon, et al.
Publicado: (2023)

Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin
por: Elsewedy, Heba S., et al.
Publicado: (2022)

Weak Knees: A Case of Atorvastatin-induced Dermatomyositis
por: Gutierrez, Edgar, et al.
Publicado: (2020)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2013)

Effects of Statins on the Epicardial Fat Thickness in Patients with Coronary Artery Stenosis Underwent Percutaneous Coronary Intervention: Comparison of Atorvastatin with Simvastatin/Ezetimibe
por: Park, Jae-Hyeong, et al.
Publicado: (2010)

Comparison of the effects of alcoholic extract of aerial parts of Anvillea garcinii and atorvastatin on the lipid profile and thyroid hormones in hypercholesterolemic rats
por: Rasekh, Fatemeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gq76m44585fgdjn2m3vap74ibb